Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) CFO Andrew Guggenhime sold 8,000 shares of the company’s stock in a transaction on Thursday, April 18th. The shares were sold at an average price of $61.27, for a total value of $490,160.00. Following the completion of the transaction, the chief financial officer now directly owns 95,679 shares […]